Curesponse Secures Additional USD 8 Million Funding for Its Breakthrough Precision Oncology Platform
November 15, 2021 14:35 ET
|
Curesponse
REẖOVOT, Israel, Nov. 15, 2021 (GLOBE NEWSWIRE) -- Curesponse (www.curesponse.com) has secured additional USD 8 million funding for its breakthrough precision oncology platform. Curesponse is a...
Radionetics Oncology Emerges from Crinetics Pharmaceuticals with a Platform and Deep Pipeline of Nonpeptide Targeted Radiopharmaceutical Drug Candidates for Precision Oncology
October 18, 2021 16:00 ET
|
Crinetics Pharmaceuticals, Inc.
Co-founded by Crinetics, 5AM Ventures and Frazier Healthcare Partners, the New Company Launches with $30M in Initial Financing Provided by 5AM and Frazier Pipeline is Built from Crinetics’ Core...
Dr. Craig Bunnell Joins Advisory Board of Cancer Diagnostic and Precision Oncology Platform Developer 4D Path
August 24, 2021 10:00 ET
|
4D Path
NEWTON, Mass., Aug. 24, 2021 (GLOBE NEWSWIRE) -- 4D Path, creator of a patented computer-aided pan-cancer diagnostic and precision oncology platform, is pleased to announce that Dr. Craig A....
Global $125+ Billion Precision Medicine Market Competition Forecast & Opportunities to 2026
June 17, 2021 05:28 ET
|
Research and Markets
Dublin, June 17, 2021 (GLOBE NEWSWIRE) -- The "Global Precision Medicine Market, By Products and Services (Precision Medicine Platforms, Precision Medicine Tools, Precision Medicine Services), By...
Cellworks CBM Clinical Study Identifies Novel Biomarkers for ATRA Benefit and Failure in AML Patients
June 04, 2021 09:00 ET
|
Cellworks Group, Inc.
SOUTH SAN FRANCISCO, Calif., June 04, 2021 (GLOBE NEWSWIRE) -- Cellworks Group, Inc., a world leader in Personalized Medicine in the key therapeutic areas of Oncology and Immunology, today announced...
World-Renowned Cancer Oncologist, Health Consultant and Entrepreneur Dr. Nelson Teich Added to 4D Path’s Distinguished Advisory Board
May 04, 2021 10:00 ET
|
4D Path
NEWTON, Mass., May 04, 2021 (GLOBE NEWSWIRE) -- 4D Path, creator of a patented computer-aided cancer diagnostic and precision oncology platform, is pleased to announce that Dr. Nelson Teich, MD,...
HEALTHTECH SOLUTIONS, INC. ANNOUNCES CONTRACT TO ACQUIRE VARIAN BIOPHARMACEUTICALS, A PRECISION ONCOLOGY COMPANY
March 31, 2021 15:11 ET
|
Healthtech Solutions, Inc.
NEW YORK, March 31, 2021 (GLOBE NEWSWIRE) -- via InvestorWire – Healthtech Solutions, Inc. (OTC: HLTT) (“HLTT” or the “Company”) today announces that it has entered into an agreement to acquire a...
4D Path, University of Leeds Extend Contract to Collaboratively Validate New Technology to Help Doctors More Accurately Diagnose Breast Cancer
March 16, 2021 10:00 ET
|
4D Path
NEWTON, Mass., March 16, 2021 (GLOBE NEWSWIRE) -- 4D Path, creator of a patented computer-aided cancer diagnostic and precision oncology platform, has extended its existing partnership with the...
World Genomic Cancer Panel and Profiling Markets by Cancer and Germline/Somatic 2021-2025: New Science Creating New Market Opportunities with Regularity
February 25, 2021 04:13 ET
|
Research and Markets
Dublin, Feb. 25, 2021 (GLOBE NEWSWIRE) -- The "Genomic Cancer Panel and Profiling Markets by Cancer and Germline/Somatic Type with Screening Potential Market Size, Customized Forecasting/Analysis,...
I-O Therapy Combinations Spurring Growth of the Global Immuno-oncology Market, 2020 Report - Upcoming Product Launches in Adoptive Cell Therapy Segment Hold Future Growth Potential
February 17, 2021 08:38 ET
|
Research and Markets
Dublin, Feb. 17, 2021 (GLOBE NEWSWIRE) -- The "I-O Therapy Combinations Spurring Growth of the Global Immuno-oncology Market" report has been added to ResearchAndMarkets.com's offering. This...